Unlocking Lab Efficiency: The Five Dimensions of Digital Transformation
Jun. 18, 2024 | 8:00 am PT, 11:00 am ET, 17:00 CET
In TODAY's GEN webinar, industry experts Jim Brown and Kirsten Gesenberg provide a comprehensive approach to lab digital transformation. During the webinar, you’ll learn how to enhance lab operations with streamlined workflows and improved data management, how to boost overall business performance though increased efficiency and productivity, and how to navigate the digital transformation journey with confidence.
Outsourcing Strategies to Simplify and Accelerate RNA-LNP Development
Jun. 20, 2024 | 1:00 pm PT, 4:00 pm ET, 22:00 CET
In TODAY's GEN webinar, three experts in nanomedicine will share insights into critical aspects of mRNA-LNP formulation, process development, and novel analytical methods that will help shape the future of therapeutics development.
Navigating the Organ-on-Chip Landscape: Latest Regulatory Insights and the Path to Widespread Adoption
Jul. 15, 2024 | 11:00 am PT, 2:00 pm ET, 20:00 CET
In Monday's GEN Learning Lab, CN Bio’s CSO Tomasz Kostrzewski, PhD, and toxicology consultant Clive Roper, PhD, will discuss all things OOC, including current applications, the evolving perspective of regulators, and ongoing efforts to harness OOCs’ potential in biomedicine.
Endpoints: Considerations for Hit to Lead Selection of a Bispecific Antibody in Oncology
Jul. 16, 2024 | 1:00 pm PT, 4:00 pm ET, 22:00 CET
In this GEN webinar, Tavotek Biotherapeutics; CSO Mark Chiu, PhD, will present a process for selecting an EGFR x cMET bispecific antibody to treat patients with EGFR inhibitor-resistant non-small lung cancer.
Characterizing AAV Charge Heterogeneity Using High-Resolution icIEF Fractionation with LC-MS Analysis
Jul. 23, 2024 | 2:00 pm PT, 5:00 pm ET, 23:00 CET
In this GEN webinar, our speakers Xiaoping Zeng He, PhD, and Chris Heger, PhD, will discuss icIEF technology and its application to protein charge analysis in AAV gene therapy development.
Modeling Clonal Evolution in Hematopoietic Malignancies
Jul. 25, 2024 | 1:00 pm PT, 4:00 pm ET, 22:00 CET
In this GEN webinar, Robert Bowman, PhD, from the Perelman School of Medicine will discuss his lab’s approaches for modeling clonal evolution in mouse models of disease.
Strategies for Developing and Manufacturing Bispecific Antibodies and Fusion Proteins
Jul. 29, 2024 | 1:00 pm PT, 4:00 pm ET, 22:00 CET
In this GEN webinar, our speakers Xiaoyue Chenn, PhD, and Yifeng Li, PhD, will present WuXi Biologics’ suite of advanced solutions for overcoming obstacles associated with the development and manufacturing of complex biologics.
